Revvity Community
Create a narrative
WA
Based on Analyst Price Targets
Share Repurchases And AI Integration Propel Earnings And Revolutionize Diagnostics Growth
US$133.87
FV
4.6% undervalued intrinsic discount6.66%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Updated narrative